Evidence map›Paper›PMID 22672093›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2012

Antihypertensive drug use by children: are the drugs labeled and indicated?

W Pete Welch, Wenya Yang, Perdita Taylor-Zapata, Joseph T Flynn

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
7.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Hypertension in children and adolescents: perspectives in Japan.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Review
  7. Article
  8. Systematic Data Monitoring and Analysis of Cardiovascular Off-label Prescriptions in Pediatrics: Focus on Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Beta Blockers.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2022
    Article
  9. Article
  10. Pharmacologic Treatment of Pediatric Hypertension.Current hypertension reports · 2016
    Review
  11. Article
  12. Review
  13. Use of antihypertensive medications and diagnostic tests among privately insured adolescents and young adults with primary versus secondary hypertension.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2014
    Article
  14. Anti-hypertensive drugs in children and adolescents.World journal of cardiology · 2014
    Review
  15. Review
  16. Hypertension in the teenager.Pediatric clinics of North America · 2014
    Review
  17. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2013
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

W Pete WelchLewin Group, Falls Church, VA, USA.
Wenya Yang
Perdita Taylor-Zapata
Joseph T Flynn
Eunice Kennedy Shriver National Institute of Child Health and Human Development · USLewin Group (United States) · USSeattle Children's Hospital · US

Funding

Intramural NIH HHS Z99 HD999999
6 · The paper itself

Abstract

As a result of the Food and Drug Administration (FDA) Modernization Act and the Best Pharmaceuticals for Children Act, the number of medications with FDA-approved pediatric labeling has increased. To assess the success of these initiatives, we examined whether antihypertensive drugs used by children with hypertension in 2008 had FDA-approved pediatric labeling and indications. Using a nationwide commercial insurer database, 2915 children with primary (n=2607) and secondary (n=308) hypertension were identified. Drug user rate and days of supply were calculated from pharmacy claims. Drugs were categorized based on pediatric labeling and indication and whether they were recommended for pediatric use. Antihypertensive drugs were used by 889 (34%) children with primary hypertension and 200 children (65%) with secondary hypertension. User rates were 44.3% in hypertensive children younger than 6 years, 30.9% in those 6 years to older than 12 years, and 38.1% in those 12 years to older than 18 years. Seven percent of drugs were neither labeled for pediatric use nor considered recommended for use in children. In children younger than 6 years, 29% of drugs used were not indicated for use in that age group. Despite recent legislative initiatives, many drugs used by hypertensive children still lack pediatric labeling. Additional efforts are needed to close the gap between the availability of drugs that are labeled and indicated for pediatric use and actual drug usage in children.

Indexed as

Drug LabelingAdolescentAge FactorsAntihypertensive AgentsChildChild, PreschoolChild WelfareCross-Sectional StudiesFemaleHumansHypertensionInfantInfant, NewbornMalePractice Patterns, Physicians'PrevalenceAntihypertensive Agents

Identifiers

PMID22672093
PMCPMC3375915
OpenAlexW1844974430

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.